PURA Near Term $0.15 PPS Potential In What Could Be An End Of Summer Rally
August 10 2016 - 01:20PM
InvestorsHub NewsWire
New York, NY – August 10,
2016 – InvestorsHub NewsWire -- Wall Street Corner Report continues
to keep an eye on Puration, Inc. (PURA) as a yet undiscovered and
we believe, cannabis sector up and comer.
PURA Progress Over The Last 30 Days
PURA came to life on July 8, 2016 introducing a business plan to
bring a US Patent backed cannabis extraction process to market by
signing collaboration agreements with food and beverage companies
to infuse PURA cannabis extracted concentrates into food and
beverage consumer products. Shortly thereafter, the Company
released a $3 million revenue forecast.
Almost one month later, on August 2, 2016, Puration announced its first collaboration
agreement.
8 M Shares Traded; 50 M I/0; $0.04 Wtd PPS; Expanding
Shareholder Base
In the 2 years leading up to July 8, 2016, the Company only traded
500,000 shares. Since July 8th, the Company has
traded 8 million shares. With so little trading volume over
the 2 previous years and only 50 million shares issued and
out, the recent trading volume has been vital to expanding
a shareholder base. We anticipate further trading under $0.10
as the shareholder base continues to expand.
The 52 week PPS range is $0.0071 - $0.10. With the onset of
more meaningful trading since July 8, 2016, the range has been
$0.025 - $0.089. The wtd avg PPS is $0.041. Daily
trading volumes have been sporadic but the daily average has been
increasing. So far, the Company has only had one day where
the trading volume exceeded 1 million shares.
$0.15 PPS Near Term Potential; $0.45 Mid Term Potential;
$0.90 Upside Potential
Wall Street Corner Report continues to contend that PURA is an
entrepreneurial and earlier stage comparable company to GW
Pharmaceuticals (GWPH). Both are developing commercial
applications of patented cannabis extracts.
GWPH is currently valued and approximately 33 times revenue based
on collaboration agreements that include future payments on
currently booked revenue. PURA has signed its first of three
anticipated $1 million collaboration agreements. At a
more than 50% discount of GWPH’s valuation (15 times revenue) and
accounting for the possible risk of increase to the current 50
million shares issued and out, the recently announced $1 million
collaboration agreement at 15 times revenue and allowing for as
many as 100 million shares issued and out would equate to a PPS of
$0.15. If PURA is successful in signing the
additional collaboration agreements that make up the Company’s $3
million forecast, the valuation formula above would equate to a
$0.54 PPS. At a 50 million issued and outstanding level, the
valuation formula above equates to a $0.90 PPS.
Wall Street Corner Report is not the only one paying attention to
PURA’s potential. PURA was last week featured by CFN
Media Groups:
Puration (PURA) First of Three
Anticipated Collaboration Agreements
Financial News Media also featured PURA in an article about leading
cannabis companies that included PURA amongst other leading
companies to include PharmaCyte
Biotech, Inc. (OTC: PMCB),GrowLife,
Inc. (OTC: PHOT), Hemp,
Inc. (OTC: HEMP) & Medical
Marijuana, Inc. (OTC: MJNA)
PURA Summer Rally
Candidate
August is a slow month for the public markets and not the best time
to introduce a new business plan for a public company. PURA’s
potential may not be realized until after Memorial Day when the
full market returns to work after the summer holidays. On the
other hand, with many public companies gearing down IR and PR
efforts during the summer months, a company that ups its IR/PR game
during the otherwise slow summer can become a standout and benefit
from a summer rally.
To learn more about
Puration:
www.purationinc.com
Follow Puration on
Twitter: https://twitter.com/Puration710
Visit Puration on
Facebook: https://www.facebook.com/puration/
Wall Street Corner
Report is the
premier discovery site for promising, yet undiscovered small and
micro-cap stocks featuring opportunities in an ethical,
professional, and responsible manner. We're not fiendishly 'short'
sighted nor are we here to dream the impossibly 'long' dream.
We take a practical view on the big ideas of well-intentioned
management and look to profit on each reasonably achievable step
the well intentioned mangers take toward their big
ideas.
http://www.wallstreetcornerreport.com/
https://twitter.com/WallStCornerRpt
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and as such, may involve risks and
uncertainties. These forward looking statements relate to, amongst
other things, current expectation of the business environment in
which the company operates, potential future performance,
projections of future performance and the perceived opportunities
in the market. The company's actual performance, results and
achievements may differ materially from the expressed or implied in
such forward-looking statements as a result of a wide range of
factors.
Jack Taylor
info@wallstreetcornerreport.com
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Mar 2023 to Mar 2024